Responses
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015
- Published on: 23 November 2015
- Published on: 23 November 2015Reproductability of N-terminal BNP in stable patients with systelic heart failureShow More
Dear Editor
We have read with great interest the recent editorial about B type natriuretic peptide (BNP) by MR Cowie [1].
Treatment monitoring could be an especially interesting role of this peptide. We report our experience about the reproducibility of N terminal proBNP (NT-proBNP) in patients with stable chronic symptomatic heart failure of any aetiology with systolic heart failure.
We recruited 34...
Conflict of Interest:
None declared. - Published on: 23 November 2015Is it cost effective?Show More
Dear Editor
As mentioned in the editorial, BNP has a very good negative predictive value. This was noted in the North Glasgow study. So patients who present with acute breathing difficulties and have a negative BNP are very unlikely to have ventricular dysfunction.
Other diagnosis would have to be considered but will this prevent us from performing echocardiograms on this set of patients to definitely ru...
Conflict of Interest:
None declared. - Published on: 23 November 2015BNP testing - jumping the gunShow More
Dear Editor
The current evidence does not support the recommendation of Prof. Cowie [1]. and NICE [2]. that BNP testing is an acceptable method to rule out heart failure. Cowie takes an even more restrictive view than the NICE guidance and suggests limiting BNP testing to newly presenting patients not yet on treatment, whilst NICE makes no such distinction. Even in this more restricted setting, the New Zealand t...
Conflict of Interest:
None declared.